Ads
related to: huntington's disease treatment- Huntington's Disease
Access a Free Treatment Guide.
Learn About Huntington's Disease.
- Movement Disorders
Download a Free Treatment Guide
Learn More About Movement Disorders
- Top Neurology Specialists
Discover the Best Options to
Treat Neurological Conditions
- Need a Second Opinion?
Put Our Expertise to Work for You.
Get a Virtual Second Opinion Today.
- Huntington's Disease
Search results
FDA lifts hold on PTC Huntington’s disease trial
BioPharma Dive via Yahoo Finance· 5 hours agoPTC’s data is less mature than UniQure’s, but Wall Street analysts viewed the update as encouraging. In addition to the 10 milligram dose, the company...
New Study Reveals How the Brain Is Affected by Huntington’s Disease
SciTechDaily· 7 days agoA recent study on Huntington’s disease demonstrates its effect on brain vasculature, offering...
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with...
Morningstar· 3 days agoThe joint effort to develop treatments for cancers using a novel target has resulted in the successful identification of a new lead series of small molecules that modulate ...
From the Darién Gap to ‘The Great Dictator’
New York Times· 8 hours agoFor his latest art project, Javier Téllez makes eight Venezuelan migrants his collaborators on a film about power. “If you can reverse the order, at...
Growing use of Ozempic, other weight-loss drugs boosts clothing sales, cuts food spending
Newsday· 8 hours agoPenny Lane Boutique has seen a surge in customers buying smaller-size wardrobes in the past six...
Scotiabank maintains $19 target on Sage Therapeutics stock By Investing.com
Investing.com· 7 days agoThe endorsement follows a survey of 88 physicians that revealed strong recognition and satisfaction...
Analysts Set Annexon, Inc. (NASDAQ:ANNX) Price Target at $15.33
ETF DAILY NEWS· 7 days agoShares of Annexon, Inc. (NASDAQ:ANNX – Get Free Report) have been given a consensus rating of “Buy” by the six research firms that are currently covering the firm, Marketbeat Ratings reports ...
Jeannette Potts Sells 4,781 Shares of uniQure (NASDAQ:QURE) Stock
ETF DAILY NEWS· 1 day agoFollowing the completion of the sale, the insider now owns 91,819 shares in the company, valued at $457,258.62. The firm had revenue of $8.49 million for the quarter, compared to the consensus estimate of $2.58 million.
Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
Investor's Business Daily· 6 days agoNeurocrine Biosciences continues to put up really healthy numbers, with an ostensible 335% profit...
“I’m a Dietitian, and Here’s Why an Overly Restrictive Diet Can Backfire”
Woman's World via Yahoo News· 3 days agoFinally, you can enjoy your "feast" item, which is the food that you want to eat. That's especially...
Ad
related to: huntington's disease treatment
